Menu
GWAS Study

Multi-ancestry meta-analysis identifies genetic modifiers of age-at-onset of Alzheimer's disease at known and novel loci.

Blue EE, Broome J, Xue D et al.

40883957 PubMed ID
GWAS Study Type
41527 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BE
Blue EE
BJ
Broome J
XD
Xue D
KH
Kingston H
CN
Chapman NH
GS
Gogarten S
NA
Naj AC
WE
Wijsman EM
Chapter II

Abstract

Summary of the research findings

Introduction: Much of Alzheimer's disease (AD) risk is explained by age, apolipoprotein E (APOE) genotype, and sex. We sought to identify genetic modifiers of age at onset (AAO) of AD while probing the influence of sex and APOE among those with diverse ancestry.

27,993 European ancestry individuals, 6,949 Black individuals, 6,530 Hispanic individuals, 55 individuals

Chapter III

Study Statistics

Key metrics and study information

41527
Total Participants
GWAS
Study Type
No
Replicated
European, African unspecified, Hispanic or Latin American
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.